Bishop Daniel E. Thomas Supports Bill to End FDA Approval of Chemical Abortion Pills

| 04/2/2026

By: The Good Newsroom

The bishop emphasized the USCCB’s opposition to the chemical abortion drug not only for its purpose of terminating life, but also that the abortion pill represents an isolating and harmful response to women in need

Signage is seen outside of the Food and Drug Administration headquarters in White Oak, Maryland, August 29, 2020.
Signage is seen outside of the Food and Drug Administration headquarters in White Oak, Maryland, August 29, 2020. (OSV News photo/Andrew Kelly, Reuters)

WASHINGTON – “The abortion pill represents an isolating and harmful response to women in need,” said Bishop Daniel E. Thomas, chairman of the U.S. Conference of Catholic Bishops’ Committee on Pro-Life Activities. On Wednesday, Bishop Thomas wrote a letter to Congress in support of the “Safeguarding Women from Chemical Abortion Act,” which was recently introduced by Senator Josh Hawley and Representative Diana Harshbarger. The bill (S.4066/H.R.7902) would withdraw the U.S. Food and Drug Administration’s (FDA) approval of mifepristone for abortions.

In his letter, Bishop Thomas stated that the bill would likely save lives by curtailing the incidence of chemical abortion itself as well as its associated risks to the mothers. He emphasized the bishops’ opposition to the chemical abortion drug not only for its purpose of terminating life, but also that the abortion pill represents an isolating and harmful response to women in need.

Read Bishop Thomas’ letter here.

Watch the Easter Vigil In the Holy Night of Easter on Sunday, April 5, at 10 a.m., live from Saint Patrick's Cathedral in Manhattan.

By:

The Good Newsroom

| 04/04/2026

Watch the Easter Vigil In the Holy Night of Easter on Saturday, April 4, at 8 p.m., live from Saint Patrick's Cathedral in Manhattan.

By:

The Good Newsroom

| 04/04/2026

04:41
The solemn holy day of Good Friday was commemorated all throughout the archdiocese and its suffragan dioceses.

By:

Patrick Grady

| 04/04/2026